Predictive value of gadolinium enhancement in differentiating ALT/WD liposarcomas from benign fatty tumors.
OBJECTIVE
To determine the predictive value of gadolinium enhancement on MRI in differentiating atypical lipomatous tumor (ALT)/well-differentiated (WD) liposarcoma from benign fatty tumors.


METHODS
All histologically proven fatty tumors with preoperative gadolinium-enhanced MRI were reviewed. Only those tumors with predominantly fatty signal were included. Sensitivity, specificity, and positive and negative predictive values for both gadolinium enhancement and biopsy as predictors for the final diagnosis of ALT/WD liposarcoma were calculated.


METHODS
From 129 patients evaluated for fatty tumors between 1994 and 2002, the patient population was narrowed to 32 excised fatty tumors with preoperative gadolinium-enhanced MRI.


RESULTS
As a predictor of ALT/WD liposarcoma, the presence of gadolinium enhancement showed 100% sensitivity, 71% specificity, 53% positive predictive value and 100% negative predictive value. Needle or incisional biopsy yielded 57% sensitivity, 100% specificity, 100% positive predictive value and 63% negative predictive value for a diagnosis of ALT/WD liposarcoma.


CONCLUSIONS
Gadolinium enhancement of a homogeneous fatty soft tissue tumor is a sensitive screening tool to determine possible diagnosis of ALT/WD liposarcoma. Biopsy, on the other hand, is specific but insensitive.
Panzarella
M J
MJ
Department of Orthopedics, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA. panzarem@upstate.edu
Naqvi
A H
AH
Cohen
H E
HE
Damron
T A
TA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003287:Contrast Media; D003937:Diagnosis, Differential; D005260:Female; D005682:Gadolinium; D006801:Humans; D008067:Lipoma / Q000175:diagnosis*; D008080:Liposarcoma / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity
D003287:Contrast Media; D005682:Gadolinium
Skeletal Radiol. 2001 Oct;30(10):584-9
11685482
Virchows Arch. 1995;427(4):353-63
8548119
Acta Radiol. 1999 Jan;40(1):64-8
9973905
Skeletal Radiol. 1999 Mar;28(3):145-52
10231912
Acta Radiol. 1994 Jul;35(4):367-70
8011387
Skeletal Radiol. 1997 Mar;26(3):167-72
9108227
Skeletal Radiol. 1997 Mar;26(3):150-4
9108224
J Neurosurg. 1993 Feb;78(2):280-6
8421211
Sarcoma. 1997;1(3-4):175-9
18521221
Cancer. 1979 Feb;43(2):574-84
421182
Am J Clin Pathol. 1994 Nov;102(5):677-83
7942636
Acta Pathol Microbiol Immunol Scand A. 1982 Jan;90(1):27-36
7080811
Clin Orthop Relat Res. 2002 May;(398):203-11
11964652
Am J Surg Pathol. 1992 Nov;16(11):1051-8
1471725